Bitcoin remains resilient near $82,700 after a recent dip below $80,500, supported by reduced leverage and limited selling pressure, according to ARP Digital's Yusuf Fakhro. The cryptocurrency outperformed Ethereum and other altcoins despite macroeconomic challenges like rising inflation and elevated oil prices. Fakhro highlights that Bitcoin's market health is bolstered by lower leveraged trading and a stable ownership base, suggesting potential for further gains if market sentiment improves. The upcoming Federal Reserve meeting on October 27-28 is seen as a key event that could influence Bitcoin's next move amid ongoing inflation concerns and energy price volatility.
Bitcoin's resilience near $82,700 comes with a broad positive market trend on Pluang as of Oct 19, 2026 23:31 WIB. For readers following cryptocurrency markets, here is Pluang's snapshot: out of 50 major cryptocurrencies, 41 rose and 8 fell today. Notable movers include Litecoin (LTC) at Rp1.080.951 with a 3.82% gain and 81% buy order activity, Bitcoin Cash (BCH) at Rp5.011.670 with a 3.75% gain but 77% sell order activity, and Tezos (XTZ) at Rp5.463 with a 3.51% gain and 84% buy order activity.
Miracles, a personalized children's book maker, has printed more than 100,000 books, serving over 45,000 families. Each book features a unique 3D character of the child, created from a single photo, making the child the hero of the story. Books for U...
Miracles, a company specializing in personalized children's books where each child becomes the story's hero, has printed over 100,000 books for more than 45,000 families. The books are printed locally in Germany and delivered within a few days, offer...
The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
